• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2019冠状病毒病第二波疫情中毛霉病危险因素(包括糖尿病、酸中毒和血清铁)的变化趋势

Changing Trend of Risk Factors of Mucormycosis Including Diabetes, Acidosis, and Serum Iron in the Second Wave of COVID-19.

作者信息

Paidisetty Prakrut, Nagose Vaishali, Vaze Vikrant, Mahajan Neha, Rathod Shivanand

机构信息

Dr Ulhas Patil Medical College and Hospital, Jalgaon, Maharashtra India.

Department of Pathology, Dr Ulhas Patil Medical College and Hospital, Jalgaon, Maharashtra India.

出版信息

Indian J Microbiol. 2022 Dec;62(4):602-609. doi: 10.1007/s12088-022-01038-5. Epub 2022 Sep 5.

DOI:10.1007/s12088-022-01038-5
PMID:36090200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9441315/
Abstract

To analyze the clinic-pathological profile of patients presenting with mucormycosis infection to a tertiary care center during the second wave of the COVID-19 pandemic in India. This descriptive cross-sectional study was conducted in a hospital setting from April 2021 to July 2021 and analysis was carried out to find associations between the stratified data and the extent of the disease involvement based on radiological findings. Statistical tests like percentage, average, chi-square test, etc. were used wherever relevant using software called Minitab13. All the 51 patients had involvement of at least one paranasal sinus. The incidence of previously established risk factors was diabetes (66.67%), history of severe COVID-19 disease (5.88%), raised serum iron levels (1.96%), Acidosis (3.92%), steroid administration (62.75%), oxygen administration (25.49%). Elevated serum urea levels (76.47%), alkalosis in 50.98% and hyperglycemia on multiple occasions (41.17%) were observed. The mean days between start of treatment for COVID-19 and appearance of first symptom suggesting mucormycosis were found to be 27.59 days. Only in 5.88% participants mucormycosis preceded COVID-19 infection detection. The current work finds presence of traditional risk factors and associations in significantly lower frequencies than the reviewed literature. However, blood urea was elevated in three fourths of the participants. Larger scale studies in mucormycosis patients are warranted for finding the role of other risk factors including possible role of elevated blood urea and hyperglycemia in the present era.

摘要

分析在印度第二波新冠疫情期间,前往一家三级医疗中心就诊的毛霉菌病感染患者的临床病理特征。这项描述性横断面研究于2021年4月至2021年7月在医院环境中进行,并基于放射学检查结果对分层数据与疾病累及范围之间的关联进行分析。在相关情况下使用百分比、平均值、卡方检验等统计检验方法,借助名为Minitab13的软件进行分析。所有51例患者均至少累及一个鼻窦。既往已确定的危险因素发生率为:糖尿病(66.67%)、重症新冠疾病史(5.88%)、血清铁水平升高(1.96%)、酸中毒(3.92%)、使用类固醇(62.75%)、吸氧(25.49%)。观察到血清尿素水平升高(76.47%)、碱中毒(50.98%)以及多次出现高血糖(41.17%)。发现新冠治疗开始至出现提示毛霉菌病的首个症状之间的平均天数为27.59天。仅5.88%的参与者毛霉菌病先于新冠感染被发现。当前研究发现,传统危险因素及其关联的出现频率显著低于已发表文献。然而,四分之三的参与者血尿素升高。有必要对毛霉菌病患者开展更大规模的研究,以明确包括血尿素升高和高血糖在当前时代可能发挥的作用在内的其他危险因素的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e78/9705683/17311bd9a0dc/12088_2022_1038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e78/9705683/aac2579e2cc8/12088_2022_1038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e78/9705683/17311bd9a0dc/12088_2022_1038_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e78/9705683/aac2579e2cc8/12088_2022_1038_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e78/9705683/17311bd9a0dc/12088_2022_1038_Fig2_HTML.jpg

相似文献

1
Changing Trend of Risk Factors of Mucormycosis Including Diabetes, Acidosis, and Serum Iron in the Second Wave of COVID-19.2019冠状病毒病第二波疫情中毛霉病危险因素(包括糖尿病、酸中毒和血清铁)的变化趋势
Indian J Microbiol. 2022 Dec;62(4):602-609. doi: 10.1007/s12088-022-01038-5. Epub 2022 Sep 5.
2
Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.血清铁研究与 COVID 相关毛霉菌病疾病阶段的相关性。
J Assoc Physicians India. 2022 Apr;70(4):11-12.
3
Hyperferritinemia and the Extent of Mucormycosis in COVID-19 Patients.新型冠状病毒肺炎患者的高铁蛋白血症与毛霉病程度
Cureus. 2021 Dec 21;13(12):e20569. doi: 10.7759/cureus.20569. eCollection 2021 Dec.
4
Clinicopathological association of mucormycosis in COVID 19 pandemic.新型冠状病毒肺炎大流行期间毛霉菌病的临床病理关联
Indian J Pathol Microbiol. 2023 Jan-Mar;66(1):101-105. doi: 10.4103/ijpm.ijpm_699_21.
5
Epidemiology of Mucormycosis Cases During the Second Wave of COVID-19 in a Tertiary Care Institute in Western Rajasthan, India.印度拉贾斯坦邦西部一家三级医疗机构中第二波新冠疫情期间毛霉菌病病例的流行病学情况
Cureus. 2022 Mar 8;14(3):e22973. doi: 10.7759/cureus.22973. eCollection 2022 Mar.
6
Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.与 COVID-19 大流行期间毛霉菌病流行相关的危险因素。
Int J Infect Dis. 2021 Oct;111:267-270. doi: 10.1016/j.ijid.2021.08.037. Epub 2021 Aug 24.
7
COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.新型冠状病毒肺炎相关毛霉菌病:来自印度南部一家三级护理医院的病例系列
Access Microbiol. 2022 Jun 6;4(6):acmi000360. doi: 10.1099/acmi.0.000360. eCollection 2022 Aug.
8
Mucormycosis in COVID-19: A systematic review of literature.2019冠状病毒病中的毛霉病:文献系统评价
Infez Med. 2021 Dec 10;29(4):504-512. doi: 10.53854/liim-2904-2. eCollection 2021.
9
Clinical Profile of Patients Admitted With Mucormycosis During the COVID-19 Pandemic in Medicine Emergency of a Tertiary Care Hospital in North India.印度北部一家三级护理医院急诊科在新冠疫情期间收治的毛霉菌病患者的临床概况
Cureus. 2022 Sep 16;14(9):e29219. doi: 10.7759/cureus.29219. eCollection 2022 Sep.
10
As the virus sowed, the fungus reaped! A comparative analysis of the clinico-epidemiological characteristics of rhino-orbital mucormycosis before and during COVID-19 pandemic.随着病毒的传播,真菌也在收割!COVID-19 大流行前后 rhino-orbital mucormycosis 的临床流行病学特征的比较分析。
Mycoses. 2022 May;65(5):567-576. doi: 10.1111/myc.13437. Epub 2022 Apr 8.

引用本文的文献

1
Reduced serum iron levels predict poor prognosis in pulmonary mucormycosis patients: a prospective, case‒control study.血清铁水平降低预示肺毛霉病患者预后不良:一项前瞻性病例对照研究。
Sci Rep. 2025 Aug 19;15(1):30395. doi: 10.1038/s41598-025-15186-3.
2
Effect of High Serum Ferritin on Extent of Involvement of COVID-19 Associated Mucormycosis.高血清铁蛋白对新型冠状病毒肺炎相关毛霉病累及范围的影响
Indian J Otolaryngol Head Neck Surg. 2024 Apr;76(2):1857-1861. doi: 10.1007/s12070-023-04428-3. Epub 2023 Dec 19.
3
The Influences of the COVID-19 Pandemic on Infection in Children, Henan, China, 2018-2022.

本文引用的文献

1
Mucormycosis in COVID-19 Patients: A Case-Control Study.2019冠状病毒病患者的毛霉菌病:一项病例对照研究。
Microorganisms. 2022 Jun 13;10(6):1209. doi: 10.3390/microorganisms10061209.
2
Mucormycosis: time to address this deadly fungal infection.毛霉病:是时候应对这种致命的真菌感染了。
Lancet Microbe. 2021 Aug;2(8):e343-e344. doi: 10.1016/S2666-5247(21)00148-8. Epub 2021 Jun 14.
3
The Spectrum of Invasive Fungal Sinusitis in COVID-19 Patients: Experience from a Tertiary Care Referral Center in Northern India.新冠患者侵袭性真菌性鼻窦炎的谱系:来自印度北部一家三级医疗转诊中心的经验
2018 - 2022年中国河南新冠疫情对儿童感染情况的影响
Indian J Microbiol. 2024 Mar;64(1):264-266. doi: 10.1007/s12088-023-01177-3. Epub 2024 Jan 2.
4
Comparative Study of Clinical Severity and Biochemical Markers in Pre COVID-19 and COVID-19 Rhino-Orbito Cerebral Mucormycosis.新冠病毒感染前与新冠病毒感染相关鼻眶脑型毛霉菌病的临床严重程度及生化标志物对比研究
Indian J Otolaryngol Head Neck Surg. 2023 Mar 17;75(3):1-6. doi: 10.1007/s12070-023-03645-0.
J Fungi (Basel). 2022 Feb 24;8(3):223. doi: 10.3390/jof8030223.
4
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries.COVID-19 相关毛霉病的出现:来自 18 个国家的病例回顾。
Lancet Microbe. 2022 Jul;3(7):e543-e552. doi: 10.1016/S2666-5247(21)00237-8. Epub 2022 Jan 25.
5
Mucormycosis and COVID-19: An epidemic within a pandemic in India.毛霉菌病与 COVID-19:印度大流行中的一场流行病。
Mycoses. 2021 Oct;64(10):1253-1260. doi: 10.1111/myc.13353. Epub 2021 Jul 24.
6
When Uncontrolled Diabetes Mellitus and Severe COVID-19 Converge: The Perfect Storm for Mucormycosis.当未控制的糖尿病与重症 COVID-19 相遇:毛霉菌病的完美风暴。
J Fungi (Basel). 2021 Apr 15;7(4):298. doi: 10.3390/jof7040298.
7
SARS-CoV-2, Uncontrolled Diabetes and Corticosteroids-An Unholy Trinity in Invasive Fungal Infections of the Maxillofacial Region? A Retrospective, Multi-centric Analysis.严重急性呼吸综合征冠状病毒2型、未控制的糖尿病与皮质类固醇——颌面区域侵袭性真菌感染中的“邪恶三位一体”?一项回顾性多中心分析
J Maxillofac Oral Surg. 2021 Sep;20(3):418-425. doi: 10.1007/s12663-021-01532-1. Epub 2021 Mar 6.
8
A Case of Fatal Rhino-Orbital Mucormycosis Associated With New Onset Diabetic Ketoacidosis and COVID-19.一例与新发糖尿病酮症酸中毒和新冠肺炎相关的致命性鼻眶毛霉菌病病例
Cureus. 2021 Feb 5;13(2):e13163. doi: 10.7759/cureus.13163.
9
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.冠状病毒病(新冠-19)相关毛霉菌病(CAM):病例报告及文献系统综述
Mycopathologia. 2021 May;186(2):289-298. doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5.
10
Epidemiology and Diagnosis of Mucormycosis: An Update.毛霉病的流行病学与诊断:最新进展
J Fungi (Basel). 2020 Nov 2;6(4):265. doi: 10.3390/jof6040265.